Issue 5/2008
Content (17 Articles)
What is low-risk prostate cancer and what is its natural history?
Helen O’Donnell, Chris Parker
Algorithms, nomograms and the detection of indolent prostate cancer
Monique J. Roobol
What is the molecular pathology of low-risk prostate cancer?
Hemamali Samaratunga, Jonathan I. Epstein
Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy
Scott G. Williams, Anthony L. Zietman
Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?
Hashim Uddin Ahmed, Mark Emberton
The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research
Suzanne K. Steginga, Emma Turner, Jenny Donovan
A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies
Joshua R. Gonzalez, Melissa A. Laudano, Tara R. McCann, James M. McKiernan, Mitchell C. Benson
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer
Vincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, Eva Comperat, Raphaële Renard-Penna, Alain Haertig, Marc-Olivier Bitker, François Richard, Pierre Conort
Extra-anatomical transobturator bypass graft for femoral artery involvement by metastatic carcinoma of the penis: report of five patients
Ubirajara Ferreira, Leonardo Oliveira Reis, Lia Yumi Ikari, Walter da Silva Jr, Wagner Eduardo Matheus, Fernandes Denardi, Rafael Mamprim Stopiglia, Fábio Husseman Menezes
Three-dimensional ultrasound reconstruction of the pelvicaliceal system: an in-vitro study
Khurshid R. Ghani, James Pilcher, Uday Patel, David Rowland, Daruish Nassiri, Ken Anson
Serotonin used as prognostic marker of urological tumors
Nina Jungwirth, Lothar Haeberle, Karl Michael Schrott, Bernd Wullich, Frens Steffen Krause
Whether adrenal mass more than 5 cm can pose problem in laparoscopic adrenalectomy? An evaluation of 22 patients
Ashok K. Hemal, Ashutosh Singh, Narmada P. Gupta
Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation
Wengang Cao, Kathleen T. Shiverick, Kazunori Namiki, Yoshihisa Sakai, Stacy Porvasnik, Cydney Urbanek, Charles J. Rosser
A modified approach for feminizing genitoplasty
A. Savanelli, F. Alicchio, C. Esposito, M. De Marco, A. Settimi